Active Ingredient History

  • Now
Fosdagrocorat is a nonsteroidal but steroid-like selective glucocorticoid receptor modulator (SGRM) which was under development for the treatment of rheumatoid arthritis but was never marketed. It is the C2 dihydrogen phosphate ester of dagrocorat, and acts as a prodrug of dagrocorat with improved pharmacokinetics. The drug reached phase II clinical trials prior to the discontinuation of its development.   Wikipedia

  • SMILES: Cc1ncccc1NC(=O)c2ccc3c(CC[C@@H]4C[C@@](CC[C@@]34Cc5ccccc5)(OP(=O)(O)O)C(F)(F)F)c2
  • Mol. Mass: 574.54
  • ALogP: 6.28
  • ChEMBL Molecule:
More Chemistry
fosdagrocorat | pf-04171327


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue